ARISE-HIV LAUNCH Challenge
ARISE-HIV LAUNCH Challenge supports researchers, community groups, and cross-sector teams with prizes for ideas and plans to improve access to and sustained use of long-acting HIV prevention and treatment.
Funder: NIH Challenges
Due Dates: August 6, 2026 (Phase 1) | February 15, 2027 (Phase 2)
Funding Amounts: $1,000,000 total prize purse; up to 35 Phase 1 prizes of $10,000 and 13 Phase 2 prizes of $50,000
Summary: Cash prizes reward actionable ideas and implementation plans to improve access, delivery, engagement, and retention for long-acting HIV prevention and treatment in the United States.
Key Information: Only Phase 1 winners are invited to compete in Phase 2.
Description
The ARISE-HIV LAUNCH Challenge is a two-phase prize competition sponsored by the NIH Office of AIDS Research (OAR). It rewards innovative, pragmatic solutions to persistent barriers to implementing and scaling long-acting HIV prevention and treatment products in the United States. Phase 1 recognizes promising ideas, while Phase 2 rewards detailed implementation and evaluation plans.
The challenge focuses on access, delivery, engagement, and retention, including health system adaptation, new service models, awareness and trust, and sustained use. It welcomes contributions from researchers, community organizations, industry, individuals with lived experience, and cross-sector teams. Priorities include reaching populations underserved by existing options, addressing health system, provider, and community barriers, and developing partnerships that support feasible approaches with potential for broader adoption.
